Therapeutic Asset Ratings
470 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Trilaciclib
Endometrial Carcinoma
Sun Yat-sen University
P2
CCC
(48)
VOLITINIB
Lung Cancer
Sun Yat-sen University
P2
CCC
(48)
Zanubrutinib
Colorectal Cancer Metastatic
Sun Yat-sen University
P2
CCC
(48)
Adebrelimab
Extranodal Nasal NK/T Cell Lymphoma
Sun Yat-sen University
P1/2
CCC
(48)
Adebrelimab
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Sun Yat-sen University
P1/2
CCC
(48)
Apg-2575
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
P1/2
CCC
(48)
Carboplatin
Microsatellite Instability-high (MSI-H)
Sun Yat-sen University
P1/2
CCC
(48)
Carboplatin
Mismatch Repair-deficient (dMMR)
Sun Yat-sen University
P1/2
CCC
(48)
Famitinib
EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
Sun Yat-sen University
P1/2
CCC
(48)
Palbociclib
EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
Sun Yat-sen University
P1/2
CCC
(48)
Pamiparib
Fallopian Tube Carcinosarcoma
Sun Yat-sen University
P1/2
CCC
(48)
Selinexor
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
Sun Yat-sen University
P1/2
CCC
(48)
shr2554
Extranodal Nasal NK/T Cell Lymphoma
Sun Yat-sen University
P1/2
CCC
(48)
Surufatinib
Fallopian Tube Carcinosarcoma
Sun Yat-sen University
P1/2
CCC
(48)
Surufatinib
Ovarian Carcinoma
Sun Yat-sen University
P1/2
CCC
(48)
Toripalimab
Intestinal Flora
Sun Yat-sen University
P1/2
CCC
(48)
Tucidinostat
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Sun Yat-sen University
P1/2
CCC
(48)
Vancomycin
Intestinal Flora
Sun Yat-sen University
P1/2
CCC
(48)
Zeprumetostat
Mature T-Cell And NK-Cell Non-Hodgkin Lymphoma
Sun Yat-sen University
P1/2
CCC
(48)
Rx-Af01
Immune Checkpoint Inhibitor
Sun Yat-sen University
P1/2
CC
(47)
Vancomycin
Immune Checkpoint Inhibitor
Sun Yat-sen University
P1/2
CC
(47)
ARSONIC ACID (AS H3 O3)
Breast Cancer
Sun Yat-sen University
P2
CC
(46)
cc-5013
Colorectal Cancer
Sun Yat-sen University
P2
CC
(46)
Fluzoparib
Non-small Cell Lung Cancer
Sun Yat-sen University
P2
CC
(46)
Lucanisatuzumab
Breast Cancer
Sun Yat-sen University
P2
CC
(46)
Showing 351 to 375 of 470 assets
Previous
Page 15 of 19
Next